메뉴 건너뛰기




Volumn 28, Issue 7, 2013, Pages 1779-1786

Cholecalciferol in haemodialysis patients: A randomized, double-blind, proof-of-concept and safety study

Author keywords

Calcification; Parathormone; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; CALCIUM; COLECALCIFEROL; PARATHYROID HORMONE;

EID: 84879953710     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gft001     Document Type: Article
Times cited : (69)

References (43)
  • 2
    • 79251474745 scopus 로고    scopus 로고
    • Vitamin D supplementation in chronic kidney disease: A systematic review and metaanalysis of observational studies and randomized controlled trials
    • Kandula P, Dobre M, Schold JD et al. Vitamin D supplementation in chronic kidney disease: a systematic review and metaanalysis of observational studies and randomized controlled trials. Clin J Am Soc Nephrol 2011; 6: 50-62
    • (2011) Clin J Am Soc Nephrol , vol.6 , pp. 50-62
    • Kandula, P.1    Dobre, M.2    Schold, J.D.3
  • 3
    • 0016724254 scopus 로고
    • Effect of 25-hydroxycholecalciferol on calcium absorption in chronic renal disease
    • Rutherford WE, Blondin J, Hruska K et al. Effect of 25- hydroxycholecalciferol on calcium absorption in chronic renal disease. Kidney Int 1975; 8: 320-324
    • (1975) Kidney Int , vol.8 , pp. 320-324
    • Rutherford, W.E.1    Blondin, J.2    Hruska, K.3
  • 4
    • 0017194027 scopus 로고
    • Effects of 25-hydroxycholecalciferol on bone lesions of children with terminal renal failure
    • Witmer G, Margolis A, Fontaine O et al. Effects of 25- hydroxycholecalciferol on bone lesions of children with terminal renal failure. Kidney Int 1976; 10: 395-408
    • (1976) Kidney Int , vol.10 , pp. 395-408
    • Witmer, G.1    Margolis, A.2    Fontaine, O.3
  • 5
    • 0018691473 scopus 로고
    • Comparison of 1 alpha-hydroxycholecalciferol and 25- hydroxycholecalciferol in the treatment of renal osteodystrophy: Greater effect of 25- hydroxycholecalciferol on bone mineralization
    • Fournier A, Bordier P, Gueris J et al. Comparison of 1 alpha-hydroxycholecalciferol and 25-hydroxycholecalciferol in the treatment of renal osteodystrophy: greater effect of 25- hydroxycholecalciferol on bone mineralization. Kidney Int 1979; 15: 196-204
    • (1979) Kidney Int , vol.15 , pp. 196-204
    • Fournier, A.1    Bordier, P.2    Gueris, J.3
  • 6
    • 0031012999 scopus 로고    scopus 로고
    • How important is vitamin D deficiency in uraemia?
    • Cunningham J, Makin H. How important is vitamin D deficiency in uraemia? Nephrol Dial Transplant 1997; 12: 16-18
    • (1997) Nephrol Dial Transplant , vol.12 , pp. 16-18
    • Cunningham, J.1    Makin, H.2
  • 7
    • 31644439542 scopus 로고    scopus 로고
    • 25-hydroxyvitamin D levels and bone histomorphometry in hemodialysis renal osteodystrophy
    • Coen G, Mantella D, Manni M et al. 25-hydroxyvitamin D levels and bone histomorphometry in hemodialysis renal osteodystrophy. Kidney Int 2005; 68: 1840-1848
    • (2005) Kidney Int , vol.68 , pp. 1840-1848
    • Coen, G.1    Mantella, D.2    Manni, M.3
  • 8
    • 0020070118 scopus 로고
    • Evidence for extrarenal production of 1 alpha, 25-dihydroxyvitamin D in man
    • Lambert PW, Stern PH, Avioli RC et al. Evidence for extrarenal production of 1 alpha, 25-dihydroxyvitamin D in man. J Clin Invest 1982; 69: 722-725
    • (1982) J Clin Invest , vol.69 , pp. 722-725
    • Lambert, P.W.1    Stern, P.H.2    Avioli, R.C.3
  • 9
    • 34547208630 scopus 로고    scopus 로고
    • Expanding role for vitamin D in chronic kidney disease: Importance of blood 25-OH-D levels and extra-renal 1alphahydroxylase in the classical and nonclassical actions of 1alpha,25-dihydroxyvitamin D(3)
    • Jones G. Expanding role for vitamin D in chronic kidney disease: importance of blood 25-OH-D levels and extra-renal 1alphahydroxylase in the classical and nonclassical actions of 1alpha,25-dihydroxyvitamin D(3). Semin Dial 2007; 20: 316-324
    • (2007) Semin Dial , vol.20 , pp. 316-324
    • Jones, G.1
  • 10
    • 0023805793 scopus 로고
    • Extra-renal production of calcitriol in chronic renal failure
    • Dusso A, Lopez-Hilker S, Rapp N et al. Extra-renal production of calcitriol in chronic renal failure. Kidney Int 1988; 34: 368-375
    • (1988) Kidney Int , vol.34 , pp. 368-375
    • Dusso, A.1    Lopez-Hilker, S.2    Rapp, N.3
  • 11
    • 84857175985 scopus 로고    scopus 로고
    • Vitamin D therapy in chronic kidney disease and end stage renal disease
    • Melamed ML, Thadhani RI. Vitamin D therapy in chronic kidney disease and end stage renal disease. Clin J Am Soc Nephrol 2012; 7: 358-365
    • (2012) Clin J Am Soc Nephrol , vol.7 , pp. 358-365
    • Melamed, M.L.1    Thadhani, R.I.2
  • 12
    • 0027459195 scopus 로고
    • In vivo metabolism of the vitamin D analog, dihydrotachysterol. Evidence for formation of 1 alpha,25- and 1 beta,25-dihydroxy-dihydrotachysterol metabolites and studies of their biological activity
    • Qaw F, Calverley MJ, Schroeder NJ et al. In vivo metabolism of the vitamin D analog, dihydrotachysterol. Evidence for formation of 1 alpha,25- and 1 beta,25-dihydroxy-dihydrotachysterol metabolites and studies of their biological activity. J Biol Chem 1993; 268: 282-292
    • (1993) J Biol Chem , vol.268 , pp. 282-292
    • Qaw, F.1    Calverley, M.J.2    Schroeder, N.J.3
  • 13
    • 0035092887 scopus 로고    scopus 로고
    • Extrarenal expression of 25-hydroxyvitamin d(3)-1 alpha-hydroxylase
    • Zehnder D, Bland R, Williams MC et al. Extrarenal expression of 25-hydroxyvitamin d(3)-1 alpha-hydroxylase. J Clin Endocrinol Metab 2001; 86: 888-894
    • (2001) J Clin Endocrinol Metab , vol.86 , pp. 888-894
    • Zehnder, D.1    Bland, R.2    Williams, M.C.3
  • 14
    • 0021277322 scopus 로고
    • Defective photoproduction of cholecalciferol in normal and uremic humans
    • Jacob AI, Sallman A, Santiz Z et al. Defective photoproduction of cholecalciferol in normal and uremic humans. J Nutr 1984; 114: 1313-1319
    • (1984) J Nutr , vol.114 , pp. 1313-1319
    • Jacob, A.I.1    Sallman, A.2    Santiz, Z.3
  • 15
    • 10644280669 scopus 로고    scopus 로고
    • Vitamin D insufficiency and deficiency in chronic kidney disease. A single center observational study
    • Gonzalez EA, Sachdeva A, Oliver DA et al. Vitamin D insufficiency and deficiency in chronic kidney disease. A single center observational study. Am J Nephrol 2004; 24: 503-510
    • (2004) Am J Nephrol , vol.24 , pp. 503-510
    • Gonzalez, E.A.1    Sachdeva, A.2    Oliver, D.A.3
  • 16
    • 34250779828 scopus 로고    scopus 로고
    • Prevalence of 25(OH) vitamin D insufficiency and deficiency in chronic kidney disease stage 5 patients on hemodialysis
    • Del Valle E, Negri AL, Aguirre C et al. Prevalence of 25(OH) vitamin D insufficiency and deficiency in chronic kidney disease stage 5 patients on hemodialysis. Hemodial Int 2007; 11: 315-321
    • (2007) Hemodial Int , vol.11 , pp. 315-321
    • Del Valle, E.1    Negri, A.L.2    Aguirre, C.3
  • 17
    • 34948869354 scopus 로고    scopus 로고
    • Vitamin D levels and early mortality among incident hemodialysis patients
    • Wolf M, Shah A, Gutierrez O et al. Vitamin D levels and early mortality among incident hemodialysis patients. Kidney Int 2007; 72: 1004-1013
    • (2007) Kidney Int , vol.72 , pp. 1004-1013
    • Wolf, M.1    Shah, A.2    Gutierrez, O.3
  • 18
    • 33846808897 scopus 로고    scopus 로고
    • Prevalence of vitamin D deficiency and the safety and effectiveness of monthly ergocalciferol in hemodialysis patients
    • Saab G, Young DO, Gincherman Y et al. Prevalence of vitamin D deficiency and the safety and effectiveness of monthly ergocalciferol in hemodialysis patients. Nephron Clin Pract 2007; 105: c132-c138
    • (2007) Nephron Clin Pract , vol.105
    • Saab, G.1    Young, D.O.2    Gincherman, Y.3
  • 19
    • 44949246558 scopus 로고    scopus 로고
    • Prevalence of vitamin D [25(OH)D] deficiency and effects of supplementation with ergocalciferol (vitamin D2) in stage 5 chronic kidney disease patients
    • Blair D, Byham-Gray L, Lewis E et al. Prevalence of vitamin D [25(OH)D] deficiency and effects of supplementation with ergocalciferol (vitamin D2) in stage 5 chronic kidney disease patients. J Ren Nutr 2008; 18: 375-382
    • (2008) J Ren Nutr , vol.18 , pp. 375-382
    • Blair, D.1    Byham-Gray, L.2    Lewis, E.3
  • 20
    • 58449107131 scopus 로고    scopus 로고
    • 25-Hydroxyvitamin D3, arterial calcifications and cardiovascular risk markers in haemodialysis patients
    • Matias PJ, Ferreira C, Jorge C et al. 25-Hydroxyvitamin D3, arterial calcifications and cardiovascular risk markers in haemodialysis patients. Nephrol Dial Transplant 2009; 24: 611-618
    • (2009) Nephrol Dial Transplant , vol.24 , pp. 611-618
    • Matias, P.J.1    Ferreira, C.2    Jorge, C.3
  • 21
    • 77749301194 scopus 로고    scopus 로고
    • Clinical measures identify vitamin D deficiency in dialysis
    • Bhan I, Burnett-Bowie SA, Ye J et al. Clinical measures identify vitamin D deficiency in dialysis. Clin J Am Soc Nephrol 2010; 5: 460-467
    • (2010) Clin J Am Soc Nephrol , vol.5 , pp. 460-467
    • Bhan, I.1    Burnett-Bowie, S.A.2    Ye, J.3
  • 22
    • 77952316154 scopus 로고    scopus 로고
    • Cholecalciferol supplementation in hemodialysis patients: Effects on mineral metabolism, inflammation, and cardiac dimension parameters
    • Matias PJ, Jorge C, Ferreira C et al. Cholecalciferol supplementation in hemodialysis patients: effects on mineral metabolism, inflammation, and cardiac dimension parameters. Clin J Am Soc Nephrol 2010; 5: 905-911
    • (2010) Clin J Am Soc Nephrol , vol.5 , pp. 905-911
    • Matias, P.J.1    Jorge, C.2    Ferreira, C.3
  • 23
    • 45749148626 scopus 로고    scopus 로고
    • Serum 25-hydroxyvitamin D status and cardiovascular outcomes in chronic peritoneal dialysis patients: A 3-y prospective cohort study
    • Wang AY, Lam CW, Sanderson JE et al. Serum 25-hydroxyvitamin D status and cardiovascular outcomes in chronic peritoneal dialysis patients: a 3-y prospective cohort study. Am J Clin Nutr 2008; 87: 1631-1638
    • (2008) Am J Clin Nutr , vol.87 , pp. 1631-1638
    • Wang, A.Y.1    Lam, C.W.2    Sanderson, J.E.3
  • 24
    • 79952166216 scopus 로고    scopus 로고
    • Vitamin D status and clinical outcomes in incident dialysis patients: Results from the NECOSAD study
    • Drechsler C, Verduijn M, Pilz S et al. Vitamin D status and clinical outcomes in incident dialysis patients: results from the NECOSAD study. Nephrol Dial Transplant 2011; 26: 1024-1032
    • (2011) Nephrol Dial Transplant , vol.26 , pp. 1024-1032
    • Drechsler, C.1    Verduijn, M.2    Pilz, S.3
  • 25
    • 81155158220 scopus 로고    scopus 로고
    • Vitamin D deficiency, mortality, and hospitalization in hemodialysis patients with or without protein-energy wasting
    • Fiedler R, Dorligjav O, Seibert E et al. Vitamin D deficiency, mortality, and hospitalization in hemodialysis patients with or without protein-energy wasting. Nephron Clin Pract 2011; 119: c220-c226
    • (2011) Nephron Clin Pract , vol.119
    • Fiedler, R.1    Dorligjav, O.2    Seibert, E.3
  • 26
    • 78650228639 scopus 로고    scopus 로고
    • Impact of hypovitaminosis D and alfacalcidol therapy on survival of hemodialysis patients: Results from the French ARNOS study
    • Jean G, Lataillade D, Genet L et al. Impact of hypovitaminosis D and alfacalcidol therapy on survival of hemodialysis patients: results from the French ARNOS study. Nephron Clin Pract 2011; 118: c204-c210
    • (2011) Nephron Clin Pract , vol.118
    • Jean, G.1    Lataillade, D.2    Genet, L.3
  • 27
    • 80051919112 scopus 로고    scopus 로고
    • Vitamin D status and mortality risk in CKD: A meta-analysis of prospective studies
    • Pilz S, Iodice S, Zittermann A et al. Vitamin D status and mortality risk in CKD: a meta-analysis of prospective studies. Am J Kidney Dis 2011; 58: 374-382
    • (2011) Am J Kidney Dis , vol.58 , pp. 374-382
    • Pilz, S.1    Iodice, S.2    Zittermann, A.3
  • 28
    • 69249219338 scopus 로고    scopus 로고
    • Vitamin D affects survival independently of vascular calcification in chronic kidney disease
    • Barreto DV, Barreto FC, Liabeuf S et al. Vitamin D affects survival independently of vascular calcification in chronic kidney disease. Clin J Am Soc Nephrol 2009; 4: 1128-1135
    • (2009) Clin J Am Soc Nephrol , vol.4 , pp. 1128-1135
    • Barreto, D.V.1    Barreto, F.C.2    Liabeuf, S.3
  • 29
    • 68949114585 scopus 로고    scopus 로고
    • KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD)
    • KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD). Kidney Int Suppl 2009; 113: S1-130
    • (2009) Kidney Int Suppl , vol.113
  • 30
    • 49649118377 scopus 로고    scopus 로고
    • Pitfalls of measuring total blood calcium in patients with CKD
    • Gauci C, Moranne O, Fouqueray B et al. Pitfalls of measuring total blood calcium in patients with CKD. J Am Soc Nephrol 2008; 19: 1592-1598
    • (2008) J Am Soc Nephrol , vol.19 , pp. 1592-1598
    • Gauci, C.1    Moranne, O.2    Fouqueray, B.3
  • 31
    • 0030806999 scopus 로고    scopus 로고
    • New indices to classify location, severity and progression of calcific lesions in the abdominal aorta: A 25-year follow-up study
    • Kauppila LI, Polak JF, Cupples LA et al. New indices to classify location, severity and progression of calcific lesions in the abdominal aorta: a 25-year follow-up study. Atherosclerosis 1997; 132: 245-250
    • (1997) Atherosclerosis , vol.132 , pp. 245-250
    • Kauppila, L.I.1    Polak, J.F.2    Cupples, L.A.3
  • 32
    • 34447514029 scopus 로고    scopus 로고
    • Vitamin D deficiency
    • Holick MF. Vitamin D deficiency. N Engl J Med 2007; 357: 266-281
    • (2007) N Engl J Med , vol.357 , pp. 266-281
    • Holick, M.F.1
  • 33
    • 54149104095 scopus 로고    scopus 로고
    • Daily oral 25-hydroxycholecalciferol supplementation for vitamin D deficiency in haemodialysis patients: Effects on mineral metabolism and bone markers
    • Jean G, Terrat JC, Vanel T et al. Daily oral 25-hydroxycholecalciferol supplementation for vitamin D deficiency in haemodialysis patients: effects on mineral metabolism and bone markers. Nephrol Dial Transplant 2008; 23: 3670-3676
    • (2008) Nephrol Dial Transplant , vol.23 , pp. 3670-3676
    • Jean, G.1    Terrat, J.C.2    Vanel, T.3
  • 34
    • 71049186478 scopus 로고    scopus 로고
    • Monthly cholecalciferol administration in haemodialysis patients: A simple and efficient strategy for vitamin D supplementation
    • Jean G, Souberbielle JC, Chazot C. Monthly cholecalciferol administration in haemodialysis patients: a simple and efficient strategy for vitamin D supplementation. Nephrol Dial Transplant 2009; 24: 3799-3805
    • (2009) Nephrol Dial Transplant , vol.24 , pp. 3799-3805
    • Jean, G.1    Souberbielle, J.C.2    Chazot, C.3
  • 35
    • 56749151146 scopus 로고    scopus 로고
    • High-dose cholecalciferol to correct vitamin D deficiency in haemodialysis patients
    • Tokmak F, Quack I, Schieren G et al. High-dose cholecalciferol to correct vitamin D deficiency in haemodialysis patients. Nephrol Dial Transplant 2008; 23: 4016-4020
    • (2008) Nephrol Dial Transplant , vol.23 , pp. 4016-4020
    • Tokmak, F.1    Quack, I.2    Schieren, G.3
  • 36
    • 80052218258 scopus 로고    scopus 로고
    • High-dose cholecalciferol supplementation for vitamin D deficiency in haemodialysis patients
    • Jakopin E, Pecovnik BB, Ekart R et al. High-dose cholecalciferol supplementation for vitamin D deficiency in haemodialysis patients. J Int Med Res 2011; 39: 1099-1106
    • (2011) J Int Med Res , vol.39 , pp. 1099-1106
    • Jakopin, E.1    Pecovnik, B.B.2    Ekart, R.3
  • 37
    • 84856376868 scopus 로고    scopus 로고
    • Efficacy and safety of a short course of very-high-dose cholecalciferol in hemodialysis
    • Wasse H, Huang R, Long Q et al. Efficacy and safety of a short course of very-high-dose cholecalciferol in hemodialysis. Am J Clin Nutr 2012; 95: 522-528
    • (2012) Am J Clin Nutr , vol.95 , pp. 522-528
    • Wasse, H.1    Huang, R.2    Long, Q.3
  • 38
    • 33747075392 scopus 로고    scopus 로고
    • 25-Hydroxyvitamin D(3) suppresses PTH synthesis and secretion by bovine parathyroid cells
    • Ritter CS, Armbrecht HJ, Slatopolsky E et al. 25-Hydroxyvitamin D(3) suppresses PTH synthesis and secretion by bovine parathyroid cells. Kidney Int 2006; 70: 654-659
    • (2006) Kidney Int , vol.70 , pp. 654-659
    • Ritter, C.S.1    Armbrecht, H.J.2    Slatopolsky, E.3
  • 39
    • 84862506490 scopus 로고    scopus 로고
    • Bone-specific alkaline phosphatase concentrations are less variable than those of parathyroid hormone in stable hemodialysis patients
    • Sardiwal S, Gardham C, Coleman AE et al. Bone-specific alkaline phosphatase concentrations are less variable than those of parathyroid hormone in stable hemodialysis patients. Kidney Int 2012; 82: 100-105
    • (2012) Kidney Int , vol.82 , pp. 100-105
    • Sardiwal, S.1    Gardham, C.2    Coleman, A.E.3
  • 40
    • 49649088934 scopus 로고    scopus 로고
    • Vitamin D receptor activators can protect against vascular calcification
    • Mathew S, Lund RJ, Chaudhary LR et al. Vitamin D receptor activators can protect against vascular calcification. J Am Soc Nephrol 2008; 19: 1509-1519
    • (2008) J Am Soc Nephrol , vol.19 , pp. 1509-1519
    • Mathew, S.1    Lund, R.J.2    Chaudhary, L.R.3
  • 41
    • 84885879833 scopus 로고    scopus 로고
    • Calcification outcome in renal disease (CORD) study-two years progression and prognostic value of abdominal aortic calcification in dialysis and after renal transplantation
    • Honkanen E, Kauppila L, Wikstrom B et al. Calcification outcome in renal disease (CORD) study-two years progression and prognostic value of abdominal aortic calcification in dialysis and after renal transplantation. Nephrol Dial Transplant Plus Suppl 2008; 1: ii212
    • (2008) Nephrol Dial Transplant Plus Suppl , vol.1
    • Honkanen, E.1    Kauppila, L.2    Wikstrom, B.3
  • 42
    • 33847689708 scopus 로고    scopus 로고
    • Impact of calcium and vitamin D therapy on arterial and cardiac disease in young adults with childhood-onset end stage renal disease
    • Fournier A, Harbouche L, Mansour J et al. Impact of calcium and vitamin D therapy on arterial and cardiac disease in young adults with childhood-onset end stage renal disease. Nephrol Dial Transplant 2007; 22: 956-957
    • (2007) Nephrol Dial Transplant , vol.22 , pp. 956-957
    • Fournier, A.1    Harbouche, L.2    Mansour, J.3
  • 43
    • 33846702295 scopus 로고    scopus 로고
    • Mineral metabolism and arterial functions in end-stage renal disease: Potential role of 25-hydroxyvitamin D deficiency
    • London GM, Guerin AP, Verbeke FH et al. Mineral metabolism and arterial functions in end-stage renal disease: potential role of 25-hydroxyvitamin D deficiency. J Am Soc Nephrol 2007; 18: 613-620
    • (2007) J Am Soc Nephrol , vol.18 , pp. 613-620
    • London, G.M.1    Guerin, A.P.2    Verbeke, F.H.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.